Workflow
ESG年报解读|爱博医疗遭ESG指数剔除,数据披露少引“浅绿”质疑
688050Eyebright Medical(688050) 搜狐财经·2025-04-25 10:25

Core Viewpoint - Aibo Medical continues to drive high-quality development through ESG principles, showcasing a balance between technological leadership and social responsibility, with a focus on core products and a dual strategy of "medical + consumer" [2] Environmental Dimension - Aibo Medical has been recognized as a water-saving enterprise in Beijing and has implemented water-saving technologies such as membrane separation and rainwater harvesting for irrigation [3] - The company has achieved ISO 50001 energy management certification and improved energy efficiency through various initiatives, including variable frequency technology and energy-saving lighting, expected to save nearly 10,000 kWh annually [3] Social Dimension - Aibo Medical has established the "Puno Tong Starfire Program" in collaboration with five universities to cultivate talent and has organized 61 academic conferences, enhancing industry standards and academic influence [3] - The company has partnered with Meituan to launch the first 24-hour smart store for contact lenses, improving consumer convenience through automation [3] Governance Dimension - Aibo Medical's R&D investment reached 160 million yuan in 2024, a year-on-year increase of 20.8%, with a total of 417 patent applications and 256 granted patents [5] - The company has been recognized for its governance transparency, receiving an A-level rating for information disclosure from the Shanghai Stock Exchange for two consecutive years [2] ESG Challenges - Aibo Medical was removed from the "Huaxia-Wind ESG Dandelion 50 Index" due to a decline in ESG scores, indicating areas for improvement in climate action and resource recycling disclosures [6] - The company lacks quantifiable targets for carbon emissions reduction and renewable energy usage, which are critical for assessing its climate action effectiveness [7] - There is insufficient disclosure regarding waste management and resource recycling, making it difficult to evaluate the company's environmental performance [7][8] Employee Welfare - While Aibo Medical has implemented measures for employee rights and training, there is a need for improvement in the depth and breadth of employee care compared to industry leaders [8] - The company has not disclosed detailed employee demographics or turnover rates, limiting external understanding of its human resource management practices [8] Quality Control - Aibo Medical faced a product recall due to a quality issue with a specific batch of soft hydrophilic contact lenses, highlighting the importance of quality management alongside capacity expansion [9]